Polymorphonuclear blood leukocytes and restenosis after intracoronary implantation of drug-eluting stents

Can J Physiol Pharmacol. 2009 Feb;87(2):130-6. doi: 10.1139/Y08-107.

Abstract

Peripheral blood contents of osteonectin-positive progenitor cells and polymorphonuclear granulocytes were examined by flow cytometry in 38 patients after myocardial revascularisation with drug-eluting stents. Repeat coronary angiography performed 6-12 months after stent implantation revealed in-stent restenosis in 15 patients and its absence in 23 patients. The plasma levels of osteonectin-positive progenitor cells, neutrophils, and basophils did not differ in patients with and without restenosis. Eosinophil blood levels in patients with and without restenosis were 262+/-68 and 124+/-67 cells/microL (mean+/-SD, p<0.001), respectively. Only one of 19 patients (5%) with eosinophil content lower than the distribution median for the entire group developed restenosis, whereas in the group with eosinophil contents higher than the median (n=19) restenosis occurred in 14 patients (74%, p<0.001). Our findings suggest that the frequency of restenoses after stenting is related to high peripheral blood eosinophil content.

MeSH terms

  • Adult
  • Aged
  • Angioplasty, Balloon, Coronary / adverse effects*
  • Angioplasty, Balloon, Coronary / instrumentation
  • Case-Control Studies
  • Coronary Angiography
  • Coronary Artery Disease / blood
  • Coronary Artery Disease / diagnostic imaging
  • Coronary Artery Disease / therapy*
  • Coronary Restenosis / blood
  • Coronary Restenosis / diagnostic imaging
  • Coronary Restenosis / etiology*
  • Drug-Eluting Stents*
  • Eosinophilia / blood
  • Eosinophilia / etiology*
  • Female
  • Flow Cytometry
  • Humans
  • Leukocyte Count
  • Male
  • Middle Aged
  • Neutrophils / metabolism*
  • Osteonectin / blood*
  • Platelet Aggregation Inhibitors / therapeutic use
  • Time Factors
  • Treatment Outcome

Substances

  • Osteonectin
  • Platelet Aggregation Inhibitors